Titrating-Dose of Lonafarnib in Combination With Ritonavir

NCT02527707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Delta Hepatitis

Interventions

DRUG: lonafarnib
DRUG: Ritonavir

Sponsor

Eiger BioPharmaceuticals

Collaborators

[object Object]